Extracellular Vesicles As Innovative Treatment Strategy for Amyotrophic Lateral Sclerosis

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2021 Dec 3

PMID 34858980

Citations 9

Authors

Ke Wang

Yu Li

Chao Ren

Yongjing Wang

Wenshan He

Yuan Jiang

Affiliations

Soon will be listed here.

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive and fatal motor neuron degenerative disease, and it is hard to diagnose in the early stage, and treatment means are limited, and the treatment effect is unsatisfactory. Therefore, exploring a new effective treatment strategy is urgently needed for ALS patients. Extracellular vesicles (EVs) are a heterogeneous group of natural membrane vesicles containing many bioactive substances, and they play important roles in the paracrine pathway and exhibit neuroprotection effects. A growing body of evidence shows that EVs have great application potential in diagnosis, treatment, and drug delivery in ALS, and they represent an innovative treatment strategy for ALS. In this review, we will briefly introduce the biogenesis of EVs and focus on discussing the role of EVs in ALS treatment to further enrich and boost the development of EVs as an innovative treatment strategy for ALS.

Citing Articles

Brown Adipose Tissue undergoes pathological perturbations and shapes C2C12 myoblast homeostasis in the SOD1-G93A mouse model of Amyotrophic Lateral Sclerosis.

Rosina M, Scaricamazza S, Riggio F, Fenili G, Giannessi F, Matteocci A Heliyon. 2025; 11(3):e41801.

PMID: 39916853 PMC: 11800085. DOI: 10.1016/j.heliyon.2025.e41801.

Therapeutic potential of mesenchymal stem cell-derived exosomes and miRNAs in neuronal regeneration and rejuvenation in neurological disorders: a mini review.

Salehpour A, Karimi Z, Ghasemi Zadeh M, Afshar M, Kameli A, Mooseli F Front Cell Neurosci. 2024; 18:1427525.

PMID: 39429946 PMC: 11486650. DOI: 10.3389/fncel.2024.1427525.

Comparing preprocessing strategies for 3D-Gene microarray data of extracellular vesicle-derived miRNAs.

Takemoto Y, Ito D, Komori S, Kishimoto Y, Yamada S, Hashizume A BMC Bioinformatics. 2024; 25(1):221.

PMID: 38902629 PMC: 11188187. DOI: 10.1186/s12859-024-05840-4.

Advances in Exosome-Based Therapies for the Repair of Peripheral Nerve Injuries.

Rahimian S, Najafi H, Webber C, Jalali H Neurochem Res. 2024; 49(8):1905-1925.

PMID: 38807021 DOI: 10.1007/s11064-024-04157-1.

ALPL regulates pro-angiogenic capacity of mesenchymal stem cells through ATP-P2X7 axis controlled exosomes secretion.

Dong J, Zhao W, Zhao J, Chen J, Liu P, Zheng X J Nanobiotechnology. 2024; 22(1):172.

PMID: 38609899 PMC: 11015668. DOI: 10.1186/s12951-024-02396-6.

References

Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T . Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci. 2015; 18(11):1584-93. PMC: 4694577. DOI: 10.1038/nn.4132. View

Thompson A, Gray E, Mager I, Thezenas M, Charles P, Talbot K . CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis. Clin Proteomics. 2020; 17:31. PMC: 7433176. DOI: 10.1186/s12014-020-09294-7. View

Silverman J, Fernando S, Grad L, Hill A, Turner B, Yerbury J . Disease Mechanisms in ALS: Misfolded SOD1 Transferred Through Exosome-Dependent and Exosome-Independent Pathways. Cell Mol Neurobiol. 2016; 36(3):377-81. PMC: 11482315. DOI: 10.1007/s10571-015-0294-3. View

Gassama Y, Favereaux A . Emerging Roles of Extracellular Vesicles in the Central Nervous System: Physiology, Pathology, and Therapeutic Perspectives. Front Cell Neurosci. 2021; 15:626043. PMC: 7940515. DOI: 10.3389/fncel.2021.626043. View

Saucier D, Wajnberg G, Roy J, Beauregard A, Chacko S, Crapoulet N . Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients. Brain Res. 2018; 1708:100-108. DOI: 10.1016/j.brainres.2018.12.016. View

Iguchi Y, Eid L, Parent M, Soucy G, Bareil C, Riku Y . Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain. 2016; 139(Pt 12):3187-3201. PMC: 5840881. DOI: 10.1093/brain/aww237. View

Sproviero D, La Salvia S, Giannini M, Crippa V, Gagliardi S, Bernuzzi S . Pathological Proteins Are Transported by Extracellular Vesicles of Sporadic Amyotrophic Lateral Sclerosis Patients. Front Neurosci. 2018; 12:487. PMC: 6060258. DOI: 10.3389/fnins.2018.00487. View

Izadpanah M, Seddigh A, Barough S, Shahzadeh Fazeli S, Ai J . Potential of Extracellular Vesicles in Neurodegenerative Diseases: Diagnostic and Therapeutic Indications. J Mol Neurosci. 2018; 66(2):172-179. DOI: 10.1007/s12031-018-1135-x. View

Bonafede R, Brandi J, Manfredi M, Scambi I, Schiaffino L, Merigo F . The Anti-Apoptotic Effect of ASC-Exosomes in an In Vitro ALS Model and Their Proteomic Analysis. Cells. 2019; 8(9). PMC: 6770878. DOI: 10.3390/cells8091087. View

10.

Dinkins M, Dasgupta S, Wang G, Zhu G, Bieberich E . Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease. Neurobiol Aging. 2014; 35(8):1792-800. PMC: 4035236. DOI: 10.1016/j.neurobiolaging.2014.02.012. View

11.

Li X, Zhang J, Li D, Wu W, Xie Z, Liu Q . Physiological and pathological insights into exosomes in the brain. Zool Res. 2020; 41(4):365-372. PMC: 7340524. DOI: 10.24272/j.issn.2095-8137.2020.043. View

12.

Ciregia F, Urbani A, Palmisano G . Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases. Front Mol Neurosci. 2017; 10:276. PMC: 5583211. DOI: 10.3389/fnmol.2017.00276. View

13.

Wang J, Hu W, Jiang Z, Feng M . Advances in treatment of neurodegenerative diseases: Perspectives for combination of stem cells with neurotrophic factors. World J Stem Cells. 2020; 12(5):323-338. PMC: 7280867. DOI: 10.4252/wjsc.v12.i5.323. View

14.

Fernandes M, Lopes I, Teixeira J, Botelho C, Gomes A . Exosome-like Nanoparticles: A New Type of Nanocarrier. Curr Med Chem. 2019; 27(23):3888-3905. DOI: 10.2174/0929867326666190129142604. View

15.

Jia G, Han Y, An Y, Ding Y, He C, Wang X . NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. Biomaterials. 2018; 178:302-316. DOI: 10.1016/j.biomaterials.2018.06.029. View

16.

Collino F, Deregibus M, Bruno S, Sterpone L, Aghemo G, Viltono L . Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One. 2010; 5(7):e11803. PMC: 2910725. DOI: 10.1371/journal.pone.0011803. View

17.

Varcianna A, Myszczynska M, Castelli L, ONeill B, Kim Y, Talbot J . Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS. EBioMedicine. 2019; 40:626-635. PMC: 6413467. DOI: 10.1016/j.ebiom.2018.11.067. View

18.

Bonafede R, Turano E, Scambi I, Busato A, Bontempi P, Virla F . ASC-Exosomes Ameliorate the Disease Progression in SOD1(G93A) Murine Model Underlining Their Potential Therapeutic Use in Human ALS. Int J Mol Sci. 2020; 21(10). PMC: 7279464. DOI: 10.3390/ijms21103651. View

19.

Vassileff N, Cheng L, Hill A . Extracellular vesicles - propagators of neuropathology and sources of potential biomarkers and therapeutics for neurodegenerative diseases. J Cell Sci. 2020; 133(23). DOI: 10.1242/jcs.243139. View

20.

Brettschneider J, Del Tredici K, Lee V, Trojanowski J . Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat Rev Neurosci. 2015; 16(2):109-20. PMC: 4312418. DOI: 10.1038/nrn3887. View